| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/24/2003 | WO2003106423A1 Cyclic amine and medicinal composition containing the same |
| 12/24/2003 | WO2003106418A1 Indole, indazole, and benzazole derivative |
| 12/24/2003 | WO2003106410A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 12/24/2003 | WO2003106405A1 Aspartyl protease inhibitors |
| 12/24/2003 | WO2003106403A1 Carboxamides derivatives |
| 12/24/2003 | WO2003106401A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/24/2003 | WO2003106380A2 Fluorobenzamides |
| 12/24/2003 | WO2003105910A1 Metallothionein based neuronal therapeutic and therapeutic methods |
| 12/24/2003 | WO2003105902A1 Treatment for depression and anxiety by the combination of a pde iv inhibitor and an antidepressant or an anxiolytic agent |
| 12/24/2003 | WO2003105893A2 Probiotic therapies |
| 12/24/2003 | WO2003105872A1 Anti-spasmodic comprising xenon |
| 12/24/2003 | WO2003105871A1 Cerebral protection with a gas comprising xenon |
| 12/24/2003 | WO2003105868A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | WO2003105852A1 Use of dopamine partial agonists for the treatment of the restless legs syndrome and corresponding pharmaceutical preparation |
| 12/24/2003 | WO2003105847A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003105838A2 Metabolite |
| 12/24/2003 | WO2003105834A1 Bazedoxifene treatment regimens |
| 12/24/2003 | WO2003105833A1 Formulation of nefopam and its use in the treatment of pain |
| 12/24/2003 | WO2003105832A1 Use of nefopam for the treatment of nausea or emesis |
| 12/24/2003 | WO2003105830A1 Medicinal compositions improving brain function and method for improving brain function |
| 12/24/2003 | WO2003105815A1 Combination of pde-v inhibitors and nk1 antagonists for the treatment of depression |
| 12/24/2003 | WO2003105808A1 Abuse-protected administration form |
| 12/24/2003 | WO2003105804A1 Ibuprofen suspension |
| 12/24/2003 | WO2003105800A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/24/2003 | WO2003105781A2 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003105779A2 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 12/24/2003 | WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 12/24/2003 | WO2003105724A2 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | WO2003105609A1 Infant formula supplemented with phospholipids |
| 12/24/2003 | WO2003105561A2 Method and devices for diagnosing and treating choroid plexus failure |
| 12/24/2003 | WO2003091675A3 Ultrasonic doppler effect speed measurement |
| 12/24/2003 | WO2003088765A3 Functional foods containing a phospholipid-containing stable matrix |
| 12/24/2003 | WO2003086396A9 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 12/24/2003 | WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 12/24/2003 | WO2003082807A3 Amino acids with affinity for the alpha-2-delta-protein |
| 12/24/2003 | WO2003076414A3 Aryl substituted pyrimidines and the use thereof |
| 12/24/2003 | WO2003075951A3 Novel application of vaccination against tnf-alpha |
| 12/24/2003 | WO2003075015A3 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 12/24/2003 | WO2003072558A3 Arylsulfone derivatives |
| 12/24/2003 | WO2003072548A8 Pyridyl sulfone derivatives as 5-ht receptor antagonists |
| 12/24/2003 | WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/24/2003 | WO2003068760A3 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 12/24/2003 | WO2003068166A3 Treatment of ophthalmic disorders using urea and urea derivatives |
| 12/24/2003 | WO2003066840A3 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 12/24/2003 | WO2003066806A3 Therapeutic use of aziridino compounds |
| 12/24/2003 | WO2003065044A8 Diagnostics and therapeutics for diseases associated with gpr72 |
| 12/24/2003 | WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene |
| 12/24/2003 | WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 12/24/2003 | WO2003062236A8 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES |
| 12/24/2003 | WO2003040174A3 Substituted amino ketone compounds |
| 12/24/2003 | WO2003039454A3 Beta-secretase inhibitors and methods of use |
| 12/24/2003 | WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 12/24/2003 | WO2003035137A3 Method and apparatus for dispensing inhalator medicament |
| 12/24/2003 | WO2003033048A3 Drug delivery system for conscious sedation |
| 12/24/2003 | WO2003011846B1 Process for the preparation of 5-substituted isobenzofurans |
| 12/24/2003 | WO2002102997A3 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/24/2003 | WO2002100858A8 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
| 12/24/2003 | WO2002090356A3 Method for the production of zolpidem |
| 12/24/2003 | WO2002085901A8 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists) |
| 12/24/2003 | WO2002067994A3 Compounds comprising an analgesic molecule linked to a vector that can vectorise said molecule through the hematoencephalic barrier and pharmaceutical compositions containing same |
| 12/24/2003 | WO2002046147A3 Perturbed membrane-binding compounds |
| 12/24/2003 | WO2002040006A3 Treatment of anxiety disorders |
| 12/24/2003 | WO2002038730A3 Novel human potassium channel beta subunit |
| 12/24/2003 | WO2002018540A3 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 12/24/2003 | WO2001052878A8 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 12/24/2003 | CN1463269A Phenylpiperazine |
| 12/24/2003 | CN1463192A Herb compsns. for treating dopy and agrypnia |
| 12/24/2003 | CN1463191A Low hygroscopic aripiprazole drug substance and processes for prepn. thereof |
| 12/24/2003 | CN1462620A Powder of flenabane and its preparation method as well as application in making drugs |
| 12/24/2003 | CN1462616A Method of preparing medical use injection containing high oxygen |
| 12/24/2003 | CN1131868C 作为药物的三环△3－哌啶 As a tricyclic drug △ 3- piperidine |
| 12/24/2003 | CN1131864C 吗啉衍生物的化学合成方法 Morpholine derivatives chemical synthesis |
| 12/24/2003 | CN1131861C Piperazidine deriv. and preparing method thereof |
| 12/24/2003 | CN1131860C 依来曲普坦氢溴酸盐一水合物 According to eletriptan hydrobromide monohydrate |
| 12/24/2003 | CN1131858C 旋光的氨基戊烷衍生物 Aminopentane optically active derivatives |
| 12/24/2003 | CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy |
| 12/24/2003 | CN1131712C Colostrinin and use thereof |
| 12/24/2003 | CA2489791A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of anxiety or depression |
| 12/24/2003 | CA2489466A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 12/24/2003 | CA2489450A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 12/24/2003 | CA2489447A1 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 12/24/2003 | CA2489315A1 Formulation of nefopam and its use in the treatment of pain |
| 12/24/2003 | CA2489312A1 Modulation of activation of glucocorticoid receptors .beta.-breakdown products of glucocorticoids |
| 12/24/2003 | CA2489306A1 Use of nefopam for the treatment of nausea or emesis |
| 12/24/2003 | CA2489292A1 Vectors for expression of hml-2 polypeptides |
| 12/24/2003 | CA2489252A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | CA2489249A1 Carboxamides derivatives |
| 12/24/2003 | CA2489247A1 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 12/24/2003 | CA2489245A1 Fluorinated cycloalkyl-derivatized benzoylguanidines and their use as a medicament |
| 12/24/2003 | CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/24/2003 | CA2489106A1 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/24/2003 | CA2489098A1 Bazedoxifene treatment regimens |
| 12/24/2003 | CA2489095A1 Aspartyl protease inhibitors |
| 12/24/2003 | CA2488884A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | CA2488845A1 Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension |
| 12/24/2003 | CA2488802A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | CA2488752A1 Novel maxi-k channel blockers, methods of use and process for making the same |
| 12/24/2003 | CA2488708A1 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 12/24/2003 | CA2488699A1 Indole, indazole, and benzazole derivative |
| 12/24/2003 | CA2488643A1 Coated particles, methods of making and using |